articleNatureJul 31, 2019Closed access

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

ABAmira BarkalRBRachel BrewerMMMaxim MarkovicMKMark KowarskySBSammy Barkal

Stanford University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,357
total citations
FWCI
48.10
Percentile
100%
References
29
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • SIGLEC
  • CD24
  • Monoclonal antibody
  • Cancer research
  • Macrophage
  • Immunotherapy
  • Immune system
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.